TriSalus Life Sciences, Inc.: shareholders and insiders

TLSINASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$2.32

November 20, 2026Market cap $142M

What Ploutos Investor adds for TriSalus Life Sciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 22% since Nov 10, 2026, when the 10-Q these figures come from was filed ($2.85 then, $2.22 on Nov 20, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 21, 2025 to Nov 19, 2026, from their own Form 4 filings.

12 Form 4s

Bought on the market

$3.8M

5 people

Sold on the market

$141.2K

5 people

From Nov 21, 2025 to Nov 21, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 21, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $3.8M by 5 people·sold $141.2K by 5 people

  • 2025: no buys, no sales
  • 2026: bought $3.8M by 5 people, sold $141.2K by 5 people
  • Nov 18, 2026Mary T SzelaCEO and President
    Kind
  • Nov 17, 2026Mary T SzelaCEO and President
    Kind
  • Nov 17, 2026Gary B. GordonDirector
    Kind
  • Nov 16, 2026Richard MarshakChief Commercial Officer
    Kind
  • Nov 12, 2026Mats WahlstromDirector
    Kind
  • Oct 5, 2026Bryan F. CoxChief of Research
    Kind
  • Oct 5, 2026Richard MarshakChief Commercial Officer
    Kind
  • Oct 5, 2026Jennifer StevensChief Regulatory Officer
    Kind
  • Oct 5, 2026Mary T SzelaCEO and President
    Kind
  • Jul 1, 2026David PatienceChief Financial Officer
    Kind
  • Jun 30, 2026Mary T SzelaCEO and President
    Kind
  • Jun 30, 2026Richard MarshakChief Commercial Officer
    Kind
  • Jun 29, 2026Richard Henry MarshallChief Medical Officer
    Kind
  • May 15, 2026Gary B. Gordon
    Kind
  • May 15, 2026David PatienceChief Financial Officer
    Kind
  • May 15, 2026Mary T SzelaCEO and President
    Kind
  • May 15, 2026Michael P Stansky
    Kind
  • May 15, 2026Michael P Stansky
    Kind
  • May 15, 2026Mats Wahlstrom
    Kind
  • May 15, 2026Richard MarshakChief Commercial Officer
    Kind
  • Mar 17, 2026Mary T SzelaCEO and President
    Kind
  • Mar 16, 2026Jennifer StevensChief Regulatory Officer
    Kind
  • Mar 16, 2026Richard MarshakChief Commercial Officer
    Kind
  • Mar 16, 2026Bryan F. CoxChief of Research
    Kind
  • Mar 16, 2026Jodi DevlinChief of Clinical Operations
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 29, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by TLSI's officers and directors from 2024 up to November 20, 2025, 2 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

5 Holders over 5%2 On a 13DJul 7, 2026 Latest filing
  • Frankenius Equity ABwith 1 more person
    Share of class14.0%
  • First Light Asset Management, LLCwith 1 more person
    Share of class10.7%
  • Mats Wahlstromwith 2 more persons
    Share of class6.00%
  • Utmost Group PLC
    Share of class5.71%
  • James J. Pallotta
    Share of class5.20%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Frankenius Equity AB14.0%From the filing of Aug 4, 2025

    Item 4 of the Statement is hereby amended and supplemented as follows: On June 23, 2025, the Issuer filed a Form S-4 announcing the Exchange Offer (the "Offer") of Common Stock in exchange for the shares of the Issuer's Preferred Stock, which equated to an exchange ratio of 3.3 shares of Common Stock for each share of Preferred Stock exchanged pursuant to the Offer. The Offer expired at one minute after 11:59 P.M. Eastern Daylight Time on July 23, 2025 and the conversions were completed on July 31, 2025. Frankenius Equity AB accepted the Exchange and was issued 759,000 shares of Common Stock in exchange for their 230,000 shares of Preferred Stock.

    From the filing of Aug 4, 2025
  • Mats Wahlstrom6.0%From the filing of Aug 1, 2025

    Item 4 of the Statement is hereby amended and supplemented as follows: On June 23, 2025, the Issuer filed a Form S-4 announcing the Exchange Offer (the "Offer") of Common Stock in exchange for the shares of the Issuer's Preferred Stock, which equated to an exchange ratio of 3.3 shares of Common Stock for each share of Preferred Stock exchanged pursuant to the Offer. The Offer expired at one minute after 11:59 P.M. Eastern Daylight Time on July 23, 2025 and the conversions were completed on July 31, 2025. Leonard Capital, LLC. accepted the Exchange and was issued 165,000 shares of Common Stock in exchange for their 50,000 shares of Preferred Stock.

    From the filing of Aug 1, 2025
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Nantahala Capital Management, LLC4.09%Nov 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Millennium Mgmt (Englander)
    In the quarter
  • D.E. Shaw
    In the quarter
  • AQR Capital
    In the quarter-3.2%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 5.62% of its shares outstanding were held short, +2.9% since the report before.

Shares held short
3.44M
5.62%
Since the report before3.35M on Sep 30, 2026
+2.9%
20.1
171.3K
More days to cover thanof 4,578 US-listed companies with enough volume
99%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 5,720
  • Nov 15, 2023: Shares held short 3,223
  • Nov 30, 2023: Shares held short 8,580
  • Dec 15, 2023: Shares held short 66.3K
  • Dec 29, 2023: Shares held short 180.6K
  • Jan 12, 2024: Shares held short 250.6K
  • Jan 31, 2024: Shares held short 267.8K
  • Feb 15, 2024: Shares held short 252.9K
  • Feb 29, 2024: Shares held short 255.4K
  • Mar 15, 2024: Shares held short 254.9K
  • Mar 28, 2024: Shares held short 287.4K
  • Apr 15, 2024: Shares held short 276.3K
  • Apr 30, 2024: Shares held short 169.6K
  • May 15, 2024: Shares held short 172.1K
  • May 31, 2024: Shares held short 413.4K
  • Jun 14, 2024: Shares held short 421.9K
  • Jun 28, 2024: Shares held short 453.5K
  • Jul 15, 2024: Shares held short 52.3K
  • Jul 31, 2024: Shares held short 42.9K
  • Aug 15, 2024: Shares held short 41.0K
  • Aug 30, 2024: Shares held short 32.9K
  • Sep 13, 2024: Shares held short 31.5K
  • Sep 30, 2024: Shares held short 51.2K
  • Oct 15, 2024: Shares held short 62.1K
  • Oct 31, 2024: Shares held short 58.4K
  • Nov 15, 2024: Shares held short 31.8K
  • Nov 29, 2024: Shares held short 46.9K
  • Dec 13, 2024: Shares held short 57.6K
  • Dec 31, 2024: Shares held short 83.8K
  • Jan 15, 2025: Shares held short 83.0K
  • Jan 31, 2025: Shares held short 73.0K
  • Feb 14, 2025: Shares held short 128.0K
  • Feb 28, 2025: Shares held short 136.1K
  • Mar 14, 2025: Shares held short 124.0K
  • Mar 31, 2025: Shares held short 123.0K
  • Apr 15, 2025: Shares held short 26.4K
  • Apr 30, 2025: Shares held short 35.6K
  • May 15, 2025: Shares held short 109.0K
  • May 30, 2025: Shares held short 32.7K
  • Jun 13, 2025: Shares held short 119.7K
  • Jun 30, 2025: Shares held short 550.4K
  • Jul 15, 2025: Shares held short 605.3K
  • Jul 31, 2025: Shares held short 582.9K
  • Aug 15, 2025: Shares held short 552.8K
  • Aug 29, 2025: Shares held short 457.1K
  • Sep 15, 2025: Shares held short 515.4K
  • Sep 30, 2025: Shares held short 918.5K
  • Oct 15, 2025: Shares held short 730.1K
  • Oct 31, 2025: Shares held short 642.6K
  • Nov 14, 2025: Shares held short 637.3K
  • Nov 28, 2025: Shares held short 754.6K
  • Dec 15, 2025: Shares held short 794.5K
  • Dec 31, 2025: Shares held short 1.28M
  • Jan 15, 2026: Shares held short 1.26M
  • Jan 30, 2026: Shares held short 1.14M
  • Feb 13, 2026: Shares held short 1.16M
  • Feb 27, 2026: Shares held short 986.7K
  • Mar 13, 2026: Shares held short 1.08M
  • Mar 31, 2026: Shares held short 1.20M
  • Apr 15, 2026: Shares held short 1.32M
  • Apr 30, 2026: Shares held short 1.44M
  • May 15, 2026: Shares held short 1.69M
  • May 29, 2026: Shares held short 2.10M
  • Jun 15, 2026: Shares held short 2.19M
  • Jun 30, 2026: Shares held short 3.08M
  • Jul 15, 2026: Shares held short 3.56M
  • Jul 31, 2026: Shares held short 3.77M
  • Aug 14, 2026: Shares held short 3.79M
  • Aug 31, 2026: Shares held short 3.69M
  • Sep 15, 2026: Shares held short 3.35M
  • Sep 30, 2026: Shares held short 3.35M
  • Oct 15, 2026: Shares held short 3.44M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading53.2% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 53.2% of the shares in the reported trades were short sales, against 56.8% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
53.2%
The 14 beforeOct 14, 2026 – Nov 2, 2026
56.8%
Change
-3.6 pts
Short sales a dayon average, of 218.7K shares
116.2K
More than atof 3,674 US-listed companies, same days
60%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 54.2%
  • Oct 15, 2026: Short sales 26%
  • Oct 16, 2026: Short sales 86.3%
  • Oct 19, 2026: Short sales 59.3%
  • Oct 20, 2026: Short sales 51.3%
  • Oct 21, 2026: Short sales 37.7%
  • Oct 22, 2026: Short sales 47.6%
  • Oct 23, 2026: Short sales 59.7%
  • Oct 26, 2026: Short sales 62.1%
  • Oct 27, 2026: Short sales 24.2%
  • Oct 28, 2026: Short sales 66.8%
  • Oct 29, 2026: Short sales 58.8%
  • Oct 30, 2026: Short sales 64.6%
  • Nov 2, 2026: Short sales 68.7%
  • Nov 3, 2026: Short sales 74.2%
  • Nov 4, 2026: Short sales 59.8%
  • Nov 5, 2026: Short sales 58.9%
  • Nov 6, 2026: Short sales 37.4%
  • Nov 9, 2026: Short sales 72.6%
  • Nov 10, 2026: Short sales 33.3%
  • Nov 11, 2026: Short sales 58.7%
  • Nov 12, 2026: Short sales 59.6%
  • Nov 13, 2026: Short sales 78.2%
  • Nov 16, 2026: Short sales 65.4%
  • Nov 17, 2026: Short sales 49.5%
  • Nov 18, 2026: Short sales 72.7%
  • Nov 19, 2026: Short sales 59.7%
  • Nov 20, 2026: Short sales 58%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

13.72M Insiders' shares22.38% Of the company
  • Equity AB FrankeniusTenPercentOwner
    Directly6.23M
  • Mats WahlstromDirector
    Directly3.01M
  • Michael P StanskyDirector
    Directly1.24M
  • Mary T SzelaCEO and President
    Directly1.14M
  • David PatienceChief Financial Officer
    Directly261.1K
  • George Kelly MartinDirector
    Directly–
  • Arjun JJ DesaiDirector
    Directly247.1K
  • Sean MurphyChief Manuf, Strategy&Bus Dev.
    Directly–
  • Bryan F. CoxChief of Research
    Directly162.8K
  • Richard MarshakChief Commercial Officer
    Directly127.5K
  • Jennifer StevensChief Regulatory Officer
    Directly123.8K
  • Jodi DevlinChief of Clinical Operations
    Directly97.4K
  • Richard Henry MarshallChief Medical Officer
    Directly90.0K
  • Gary B. GordonDirector
    Directly82.5K
  • William ValleDirector
    Directly30.5K
  • James Emmett YoungChief Financial Officer
    Directly–

A lower bound: it counts only the 16 officers and directors with a market trade since Nov 22, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

6 ETFs holding it0.05% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.05%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

6 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

79 Managers, Q2 2026$104M Value of their positions
  • Q3 2025: Managers 56
  • Q4 2025: Managers 64
  • Q1 2026: Managers 84
  • Q2 2026: Managers 79

Institutional investors by quarter

The fund managers holding TLSI, quarter by quarter, from Q3 2023 to Q2 2025, 8 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 79 managers held 22.76M shares, worth $104M. During the quarter 12 opened a position, 17 closed one, 43 added and 10 trimmed.

The largest holders, Q2 2026

  • First Light Asset Management
    In the quarter+29%
  • BlackRock
    In the quarter+77%
  • Nantahala Capital Management
    In the quarter-3.4%
  • Vanguard Capital Management
    In the quarter+28%
  • Cerity Partners
    In the quarter+104%
  • Geode Capital Management
    In the quarter+53%
  • Gilder Gagnon Howe
    In the quarter-4.3%
  • State Street
    In the quarter+86%
  • White Pine Capital
    In the quarter+51%
  • Thompson Siegel & Walmsley
    In the quarter-8.1%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do TriSalus Life Sciences's filings show?

Who buys and sells is one part of TriSalus Life Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about TLSI's shareholders

Didn't find what you were looking for?

Ask us
Have TLSI's insiders bought or sold?

From Jun 29, 2026 to Nov 19, 2026 TriSalus Life Sciences's insiders bought $294.2K and sold $5.4K of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold TLSI?

3 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $500.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.